Company news

Telix Pharmaceuticals Limited news in 2023

Telix Pharmaceuticals Limited's news releases, calls and decks from 2023, newest first.

View company

Telix Submits BLA for TLX250-CDx for Kidney Cancer Imaging

December 18, 2023

Telix Announces Proposed Acquisition of QSAM Biosciences

November 13, 2023

First Patient Dosed in Ph III ProstACT GLOBAL Therapy Study

November 12, 2023

Telix Completes Acquisition of Lightpoint Medical

November 1, 2023

ProstACT SELECT Study of TLX591 Positive Interim Readout

October 18, 2023

Q3 2023 Business Update to Accompany Quarterly Results

October 18, 2023

Activities Report and Appendix 4C - September 2023 Quarter

October 18, 2023

1H 2023 Results Release

August 23, 2023

1H 2023 Results Presentation

August 23, 2023

1H 2023 Appendix 4D and Interim Report

August 23, 2023

First Patient Dosed in Phase 3 Illuccix China Study

August 10, 2023

Q2 2023 Business Update to Accompany Quarterly Results

July 19, 2023

Activities Report and Appendix 4C - June 2023 Quarter

July 19, 2023

Lightpoint Acquisition to Expand Telix Urologic Pipeline

June 21, 2023

Phase II study for indication expansion of TLX250-CDx doses

June 18, 2023

Annual General Meeting - Presentation

May 24, 2023

Annual General Meeting - Chairman and CEO Addresses

May 23, 2023

ZIRCON Data Presented at AUA Confirms Efficacy in 2cm Masses

April 30, 2023

Presentation to Accompany AI Development Program Update

April 26, 2023

Telix Accelerates AI Development with Dedicaid Acquisition

April 26, 2023

Q1 2023 Business update to accompany quarterly results

April 17, 2023

Appendix 4C and Activities Report - March 2023 Quarter

April 17, 2023

Telix Preclinical Development of Radiolabelled Olaratumab

April 16, 2023

Illuccix European Marketing Authorisation Application Update

April 2, 2023

FDA approval of expanded indication of Illuccix in the US

March 15, 2023

2022 Full Year Results Presentation

February 27, 2023

Appendix 4E and 2022 Annual Report

February 27, 2023

2022 Full Year Results Release

February 27, 2023

Telix Full Year Results and Investor Conference Call Details

February 20, 2023

Q4 2022 Business update to accompany quarterly results

January 17, 2023

Appendix 4C and Activities Report - December 2022 Quarter

January 17, 2023

Webcast link correction - JP Morgan Conference Presentation

January 10, 2023

Decks in 2023